{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:22:30Z","timestamp":1760188950329},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T00:00:00Z","timestamp":1202256000000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,2]]},"abstract":"<jats:p>The aim of the present study was to estimate optimum chemotherapeutic regimens for high\u2010grade mature B\u2010cell lymphoma cases with Burkitt\u2010like morphology (Burkitt's lymphoma [BL]\/Burkitt\u2010like lymphoma [BLL]) patients. We analyzed 72 BL\/BLL, including 36 with the c\u2010myc translocation (molecular BL [mBL]), 20 without it (mBL\u2010like), and 16 in whom we were uncertain regarding the existence of the c\u2010myc translocation, and compared them with 182 diffuse large B\u2010cell lymphoma (DLBCL) cases. On clinical and immunophenotypic analysis, the typical BL immunophenotype (CD10 positive, bcl\u20102 negative, and Ki\u201067 index\u00a0\u226595%) was noted in 23 (66%) and 11 (55%) of the 35 mBL and 20 mBL\u2010like patients, respectively. The presence of the c\u2010myc translocation and typical immunophenotype in BL did not affect the overall survival of BL\/BLL. There were no significant differences between the overall survival of DLBCL (45%) and BL\/BLL (50%, <jats:italic>P\u00a0=<\/jats:italic>\u00a00.85). However, the overall survival of BL\/BLL patients who received cyclophosphamide, doxorubicin, vincristine, and prednisolone\u2010related therapy (22%) was significantly lower than that of DLBCL patients (<jats:italic>P\u00a0=<\/jats:italic>\u00a00.01). In contrast, the overall survival of BL\/BLL patients who received aggressive short\u2010term chemotherapy (75%) was better than that of the patients who received cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.01). The finding was confirmed by multivariate analysis (hazard ratio 4.4; confidence interval 2.0\u20139.7; <jats:italic>P<\/jats:italic>\u00a0=\u00a00.0003). We concluded that aggressive short\u2010term chemotherapy improves survival in BL\/BLL, regardless of its genetic and immunophenotypic features. (<jats:italic>Cancer Sci<\/jats:italic> 2008; 99: 246\u2013252)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2007.00681.x","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T08:10:47Z","timestamp":1202285447000},"page":"246-252","source":"Crossref","is-referenced-by-count":13,"title":["High\u2010grade mature B\u2010cell lymphoma with Burkitt\u2010like morphology: Results of a clinicopathological study of 72 Japanese patients"],"prefix":"10.1111","volume":"99","author":[{"given":"Yuko","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritsuro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morishige","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,2,6]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"e_1_2_6_4_2","volume-title":"Pathology and Genetics of Tumours Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours","author":"Diebold JE","year":"2001"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.12.3713"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000180442.87022.08"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.5.1558"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.5.1282.1282"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.MP.0000019577.73786.64"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<145::AID-PATH819>3.0.CO;2-P"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055351"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04134.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.1.133"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428190109097730"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2001.01196.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1827.1999.00980.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65399-0"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02225.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1309\/8WYNVUTGV9RPHUQH"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000168176.71405.e5"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.21.3707"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190310001593120"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055759"},{"issue":"1","key":"e_1_2_6_24_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/annonc\/8.suppl_1.S77","article-title":"Eighty\u2010one percent event\u2010free survival in advanced Burkitt's lymphoma\/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol","volume":"8","author":"Todeschini G","year":"1997","journal-title":"Ann Oncol"},{"key":"e_1_2_6_25_2","first-page":"33","article-title":"Additional chemotherapy agents improve treatment outcome for children and adults with advanced B\u2010cell lymphomas","volume":"25","author":"Adde M","year":"1998","journal-title":"Semin Oncol"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198712030-00002"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1042\/bj3420143","article-title":"Methotrexate inhibits the first committed step of purine biosynthesis in mitogen\u2010stimulated human T\u2010lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?","volume":"342","author":"Fairbanks LD","year":"1999","journal-title":"Biochem J"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2007.00681.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2007.00681.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T22:25:05Z","timestamp":1697235905000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2007.00681.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["10.1111\/j.1349-7006.2007.00681.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2007.00681.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}